Effects of platelet suppressant, anticoagulant and fibrinolytic therapy in patients with recurrent venous thrombosis

Am J Med. 1978 Mar;64(3):441-5. doi: 10.1016/0002-9343(78)90230-9.
No abstract available

Publication types

  • Clinical Trial
  • Randomized Controlled Trial
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Aged
  • Anticoagulants / therapeutic use*
  • Blood Platelets / drug effects
  • Cell Survival / drug effects
  • Clinical Trials as Topic
  • Ethylestrenol / pharmacology
  • Ethylestrenol / therapeutic use
  • Female
  • Fibrinogen
  • Fibrinolysis
  • Fibrinolytic Agents / therapeutic use*
  • Heparin / pharmacology
  • Heparin / therapeutic use
  • Humans
  • Male
  • Middle Aged
  • Phenformin / pharmacology
  • Phenformin / therapeutic use
  • Placebos
  • Recurrence
  • Sulfinpyrazone / pharmacology
  • Sulfinpyrazone / therapeutic use
  • Thrombophlebitis / blood
  • Thrombophlebitis / drug therapy*
  • Warfarin / pharmacology
  • Warfarin / therapeutic use

Substances

  • Anticoagulants
  • Fibrinolytic Agents
  • Placebos
  • Warfarin
  • Fibrinogen
  • Heparin
  • Ethylestrenol
  • Phenformin
  • Sulfinpyrazone